Access Statistics for Francis Tapon

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Are You Paying Your Employees to Cheat? An Experimental Investigation 0 0 1 98 0 2 19 348
Diversification, Canadian Style: How many stocks are enough for diversifying Canadian institutional portfolios? 0 0 0 0 2 12 34 78
Equity Portfolio Diversification: How Many Stocks are Enough? Evidence from Five Developed Markets 1 1 5 112 30 98 192 592
Green as Strategy: Lessons from the Chemical Industry 0 0 0 0 1 1 7 276
How many stocks are enough for diversifying Canadian institutional portfolios? 0 1 1 25 5 26 43 141
Life after Bill C-91: Is There a Future for Canadian Generic Drug Manufacturers? 0 0 0 0 1 1 5 533
Outsourcing of Research by Pharmaceutical and Biotechnology Firms 0 0 0 0 1 1 5 1,657
Stock Return Volatility and the Current Internet Phenomenon 0 0 0 0 1 1 13 92
Testing Weak Form Efficiency on the Toronto Stock Exchange 0 0 0 91 2 2 14 418
The Creation of Competitive Advantage Through Research in the Pharmaceutical Industry: A Transaction Costs Analysis 0 0 0 0 2 3 10 890
The Impact of Risk Aversion and Stress on the Incentive Effect of Performance Pay 1 1 1 149 6 6 18 448
The number of stocks in your portfolio should be larger than you think: diversification evidence from five developed markets 1 2 4 20 17 42 74 143
What Australian investors need to know to diversity their portfolios 0 0 1 14 3 16 35 80
Total Working Papers 3 5 13 509 71 211 469 5,696
1 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A New Test of the Administered Pricing Hypothesis with Canadian Data 0 0 0 4 1 1 5 57
A transaction costs analysis of innovations in the organization of pharmaceutical R & D 0 0 0 76 1 1 8 191
Are You Paying Your Employees to Cheat? An Experimental Investigation 0 0 1 173 1 1 28 693
Compulsory Licensing as a Policy Instrument 0 0 0 29 2 2 6 120
Discretionary Expenditures and Profit Risk Management: The Galbraith-Caves Hypothesis 0 0 0 31 1 2 10 326
Erratum To "The Capital Asset Pricing Model: An Evaluation of Its Potential as a Strategic Planning Tool" By Thomas H. Naylor and Francis Tapon 0 0 0 3 0 0 8 26
International correlations across stock markets and industries: trends and patterns 1988-2002 0 0 0 167 1 5 23 469
Note--The Capital Asset Pricing Model and Strategic Planning: Response to Wernerfelt 0 0 0 3 1 1 3 30
Predictive blends: Fundamental Indexing meets Markowitz 0 0 1 9 2 2 10 67
Profit risk, market power and pricing decisions of large firms 0 0 0 11 3 3 8 85
Ridge Regression Estimates of the Profitability-Concentration Hypothesis: Some Canadian Evidence Revisited [Profitability and Market Structure: A Cross-Section Comparison of Canadian and American Manufacturing Industry] 0 0 0 10 1 1 4 168
Some empirical evidence on post-patent barriers to entry in the Canadian pharmaceutical industry 0 0 0 62 0 0 4 166
Testing weak form efficiency on the Toronto Stock Exchange 0 0 1 112 0 0 10 512
The Capital Asset Pricing Model: An Evaluation of its Potential as a Strategic Planning Tool 0 0 0 13 0 0 6 72
The optimal organization of research: evidence from eight case studies of pharmaceutical firms 1 1 1 65 2 2 12 218
Um estudo da difusão do emprego de energia nuclear nos serviços industriais de utilidade pública de eletricidade nos EUA 0 0 0 2 0 0 6 23
Uncertainty, Market Structure and Performance: The Galbraith-Caves Hypothesis Revisited 0 0 0 44 0 0 5 169
Total Journal Articles 1 1 4 814 16 21 156 3,392
1 registered items for which data could not be found


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
The Impact of Risk-Aversion and Stress on the Incentive Effect of Performance-Pay 0 0 0 31 0 1 22 162
Total Chapters 0 0 0 31 0 1 22 162


Statistics updated 2026-11-12